DE602007013524D1 - Erkennung und vorhersage von frühgeburten - Google Patents

Erkennung und vorhersage von frühgeburten

Info

Publication number
DE602007013524D1
DE602007013524D1 DE602007013524T DE602007013524T DE602007013524D1 DE 602007013524 D1 DE602007013524 D1 DE 602007013524D1 DE 602007013524 T DE602007013524 T DE 602007013524T DE 602007013524 T DE602007013524 T DE 602007013524T DE 602007013524 D1 DE602007013524 D1 DE 602007013524D1
Authority
DE
Germany
Prior art keywords
prediction
detection
technology described
births
early
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007013524T
Other languages
English (en)
Inventor
Lucilla Poston
Andrew Shennan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PerkinElmer Health Sciences Inc
Original Assignee
PerkinElmer LAS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PerkinElmer LAS Inc filed Critical PerkinElmer LAS Inc
Publication of DE602007013524D1 publication Critical patent/DE602007013524D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Mold Materials And Core Materials (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Holo Graphy (AREA)
DE602007013524T 2006-01-17 2007-01-17 Erkennung und vorhersage von frühgeburten Active DE602007013524D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia
PCT/GB2007/000123 WO2007083099A1 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia

Publications (1)

Publication Number Publication Date
DE602007013524D1 true DE602007013524D1 (de) 2011-05-12

Family

ID=35998177

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007013524T Active DE602007013524D1 (de) 2006-01-17 2007-01-17 Erkennung und vorhersage von frühgeburten

Country Status (11)

Country Link
US (1) US7638287B2 (de)
EP (1) EP1974220B1 (de)
JP (1) JP2009524014A (de)
AT (1) ATE504002T1 (de)
AU (1) AU2007206756B2 (de)
CA (1) CA2602681C (de)
DE (1) DE602007013524D1 (de)
ES (1) ES2364314T3 (de)
GB (1) GB0600916D0 (de)
HK (1) HK1119244A1 (de)
WO (1) WO2007083099A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2426069T3 (es) 2007-02-12 2013-10-21 A1M Pharma Ab Diagnóstico de preeclampsia
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
ES2523220T3 (es) 2008-01-25 2014-11-24 Perkinelmer Health Sciences, Inc. Métodos para determinar el riesgo de complicaciones prenatales
WO2010059952A1 (en) * 2008-11-20 2010-05-27 Perkinelmer Health Sciences, Inc. Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
US20130122529A1 (en) * 2010-03-24 2013-05-16 Preelumina Diagnostics Ab HbF AND A1M AS EARLY STAGE MARKERS FOR PREECLAMPSIA
AU2012351504C1 (en) * 2011-12-15 2018-04-26 Mycartis N.V. Biomarkers and parameters for preeclampsia
JP6663717B2 (ja) * 2012-04-24 2020-03-13 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． 子癇前症に罹患する可能性をコンピュータにより予想する方法
CA2900366A1 (en) * 2013-02-08 2014-08-14 University Of Iowa Research Foundation Diagnostic tools to predict onset of preeclampsia
US10119978B2 (en) * 2013-03-15 2018-11-06 Wallac Oy System and method for determining risk of diabetes based on biochemical marker analysis
WO2016034767A1 (en) 2014-09-02 2016-03-10 Wallac Oy Method for determining risk of pre-eclampsia
US20200395127A1 (en) * 2017-11-17 2020-12-17 University Of Washington Connected system for information-enhanced test results
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor
GB2620035A (en) * 2021-02-10 2023-12-27 Mirvie Inc Methods and systems for conducting pregnancy-related clinical trials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998028006A1 (en) 1996-12-23 1998-07-02 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
GB0026823D0 (en) 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
EP1664797B1 (de) * 2003-09-23 2015-11-11 The General Hospital Corporation Früherkennungsmethoden für präeklampsie
CA2485722A1 (en) * 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor

Also Published As

Publication number Publication date
ATE504002T1 (de) 2011-04-15
AU2007206756A1 (en) 2007-07-26
CA2602681C (en) 2017-03-14
ES2364314T8 (es) 2011-09-22
ES2364314T3 (es) 2011-08-31
AU2007206756B2 (en) 2011-06-16
EP1974220A1 (de) 2008-10-01
EP1974220B1 (de) 2011-03-30
WO2007083099A1 (en) 2007-07-26
HK1119244A1 (en) 2009-02-27
JP2009524014A (ja) 2009-06-25
US20070178530A1 (en) 2007-08-02
GB0600916D0 (en) 2006-02-22
US7638287B2 (en) 2009-12-29
CA2602681A1 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
WO2009058902A3 (en) Methods and devices for analyte detection
MX341517B (es) Biomarcadores de cancer pancreatico y usos de los mismos.
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2020004617A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
EP2394159A4 (de) Screnningverfahren für wirkstoffkandidaten zur modulation von prorenin und renin, tests für den nachweis von prorenin und darin verwendete antikörper
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
BR112013006240A2 (pt) processo para detecção, diferenciação e quantificação de populações de células-t através da tecnologia quantitativa pcr (rt-qpcr) de transcrição reversa, em tempo real
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
WO2011142781A3 (en) Pore-limit electrophoresis (ple) microchannel assays
MX2009010751A (es) Composiciones y metodos de deteccion.
WO2013090386A3 (en) Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
ATE492815T1 (de) Diagnostik-biomolekül(e)
WO2006099537A3 (en) The use of antibody-surrogate antigen systems for detection of analytes
WO2011002146A3 (ko) 악성코드 탐지시스템 및 방법
SE0602683L (sv) Diagnostisk metod
WO2011113813A3 (en) Assay for analytes based on aggregation
WO2009126889A8 (en) Assays for detecting pregnancy-associated glycoproteins
ATE449380T1 (de) System und verfahren zur quantitativen anwendungsmessung
WO2007067557A3 (en) Methods for cyclic nucleotide determination
NZ605561A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure